Login / Signup
Correction to: Effect of Renal Impairment on Pharmacokinetics and Safety of Ensitrelvir, a SARS‑CoV‑2 3CL Protease Inhibitor.
Takayuki Katsube
Safwan Kezbor
Ryosuke Shimizu
Ryuji Kubota
Published in:
Infectious diseases and therapy (2024)
Keyphrases
</>
sars cov
respiratory syndrome coronavirus